What Would Be The Pointers To The Progress Of Streptokinase Market ?

Posted by Steve Sharma on April 22nd, 2021

Streptokinase is an enzyme that is used for breaking the blood clot formed during myocardial infraction, arterial thromboembolism and pulmonary embolism. It is FDA approved and also constitutes WHO’s list of Essential Medicines. Streptokinase is a protein obtained from bacterial source and was first discovered in 1933.

Streptokinase is mostly administered intravenously with side effects like bleeding, allergies, nausea among others. The commonly used thrombolytic agent is innately secreted by numerous strains of pathogens. Since it is of bacterial origin, it is generally given only once after the first attack as later dosage may result in allergic reactions. Streptokinase is an extracellular protein and holds immense clinical importance.

Impact of COVID-19 on the global market of streptokinase can be expected in terms of disruption in supply chain, delay in manufacturing and procurements due to regulatory restrictions and local lockdowns in various countries.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/32052